It was a wakeup call and an economic blow when hearing aid manufacturer Demant's surgical arm Oticon Medical had to recall a number of cochlear implants in addition to halting the further production of the devices in mid October.
Nonetheless, Demant's other divisions have continued their forward momentum in the year's first tenth months – with so much speed that the Danish company has upgraded its already raised expectations for the full year, which were adjusted in the half-year report in August.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.